PAA 4.69% 16.8¢ pharmaust limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-135

  1. 654 Posts.
    lightbulb Created with Sketch. 491
    My pick is J & J, Roche, Merck or Eli Lilly, they are all interested in Neurology and Oncology, and have a lot of cash to spend (no other reason).

    But having said that I don’t have shares in them so I couldn’t care who is the winning bidder in the Auction to come. Pfizer can have it, if they are the highest bidder.

    As long as there is a few interested, and they battle it out.

    @Peeteepoo posted this table:

    https://hotcopper.com.au/posts/71907197/single

    https://hotcopper.com.au/data/attachments/5971/5971639-22580dc8d3328291cc9462f068f48d81.jpg
    Havenots
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.8¢
Change
0.008(4.69%)
Mkt cap ! $82.65M
Open High Low Value Volume
16.5¢ 17.5¢ 16.5¢ $253.1K 1.496M

Buyers (Bids)

No. Vol. Price($)
6 388564 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 287883 4
View Market Depth
Last trade - 15.45pm 09/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.